UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

The New England journal of medicine, 2014-07, Vol.371 (4), p.326-338

2014

Volltextzugriff (PDF)

Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis

Journal of the American Academy of Dermatology, 2016-07, Vol.75 (1), p.99-105

2016

Volltextzugriff (PDF)

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)

Dermatology and therapy, 2020-08, Vol.10 (4), p.663-670

2020

Volltextzugriff (PDF)

A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis

International Journal of Dermatology, 2010-12, Vol.49 (12), p.1368-1375

2010

Volltextzugriff (PDF)

An Open Letter to Health Canada

Journal of cutaneous medicine and surgery, 2017-05, Vol.21 (3), p.195-196

2017

Volltextzugriff (PDF)

Evaluating practice patterns for managing moderate to severe plaque psoriasis Role of the family physician

Canadian family physician, 2012-07, Vol.58 (7), p.e390-e400

2012

Volltextzugriff (PDF)

18257 Secukinumab demonstrates sustained effectiveness and safety in patients with moderate to severe plaque psoriasis: 30-month follow-up data from the PURE registry

Journal of the American Academy of Dermatology, 2020-12, Vol.83 (6), p.AB95-AB95

2020

Volltextzugriff (PDF)

Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients With Moderate-to-Severe Plaque Psoriasis: 52-Week Data From the IXORA-S Trial

Skin (Milwood, N.Y.), 2018-12, Vol.2, p.S117

2018

Volltextzugriff (PDF)

Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use

Journal of drugs in dermatology, 2013-10, Vol.12 (10), p.1122

2013

Volltextzugriff (PDF)

Skin disorders in Ashkenazi Jews: a review

International journal of dermatology, 2005-08, Vol.44 (8), p.630-635

2005

Volltextzugriff (PDF)

A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

British journal of dermatology (1951), 2014-12, Vol.171 (6), p.1508-1516

2014

Volltextzugriff (PDF)

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009

Journal of Cutaneous Medicine and Surgery, 2016-09, Vol.20 (5), p.375-431

2016

Volltextzugriff (PDF)

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials

Journal of drugs in dermatology, 2014-11, Vol.13 (11), p.1380

2014

Volltextzugriff (PDF)

Treatment of inguinal hyperhidrosis with botulinum toxin type A

International journal of dermatology, 2006-08, Vol.45 (8), p.985-986

2006

Volltextzugriff (PDF)

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

Journal of cutaneous medicine and surgery, 2011-07, Vol.15 (4), p.210-219

2011

Volltextzugriff (PDF)

Adapalene–benzoyl peroxide, a unique fixed‐dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double‐blind, controlled study in 1670 patients

British journal of dermatology (1951), 2009-11, Vol.161 (5), p.1180-1189

2009

Volltextzugriff (PDF)

Epidemiology of Moderate-to-Severe Plaque Psoriasis in a Canadian Surveyed Population

Journal of cutaneous medicine and surgery, 2010-07, Vol.14 (4), p.167-174

2010

Volltextzugriff (PDF)

A new anti-psoriatic ointment yields high efficacy irrespective of initial disease levels

Journal of the American Academy of Dermatology, 2004-03, Vol.50 (3), p.P143-P143

Wasel, Norman R

2004

Volltextzugriff (PDF)

Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations

Journal of Cutaneous Medicine and Surgery, 2011-11, Vol.15 (6), p.309-321

2011

Volltextzugriff (PDF)

A Canadian Self-Administered Online Survey to Evaluate the Impact of Moderate-to-Severe Psoriasis among Patients

Journal of cutaneous medicine and surgery, 2009-11, Vol.13 (6), p.294-302

2009

Volltextzugriff (PDF)

Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial

Archives of dermatology (1960), 2011-04, Vol.147 (4), p.429

2011

Volltextzugriff (PDF)

Lupus Vulgaris Occurring in a Locus Minoris Resistentiae

Journal of cutaneous medicine and surgery, 2009-11, Vol.13 (6), p.313-316

2009

Volltextzugriff (PDF)

Successful hair transplant of eyebrow alopecia areata

Journal of cutaneous medicine and surgery, 2005-08, Vol.9 (4), p.162-164

2005

Volltextzugriff (PDF)

Successful Hair Transplant of Eyebrow Alopecia Areata

Journal of cutaneous medicine and surgery, 2005-08, Vol.9 (4), p.162-164

2005

Volltextzugriff (PDF)

Melanoma cell death induced by sphingosine and betulinic acid [Abstract]

Clinical and investigative medicine, 1999-08, Vol.22 (4), p.162

1999

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)

A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis

An Open Letter to Health Canada

Evaluating practice patterns for managing moderate to severe plaque psoriasis Role of the family physician

18257 Secukinumab demonstrates sustained effectiveness and safety in patients with moderate to severe plaque psoriasis: 30-month follow-up data from the PURE registry

Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients With Moderate-to-Severe Plaque Psoriasis: 52-Week Data From the IXORA-S Trial

Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use

Skin disorders in Ashkenazi Jews: a review

A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials

Treatment of inguinal hyperhidrosis with botulinum toxin type A

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

Adapalene–benzoyl peroxide, a unique fixed‐dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double‐blind, controlled study in 1670 patients

Epidemiology of Moderate-to-Severe Plaque Psoriasis in a Canadian Surveyed Population

A new anti-psoriatic ointment yields high efficacy irrespective of initial disease levels

Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations

A Canadian Self-Administered Online Survey to Evaluate the Impact of Moderate-to-Severe Psoriasis among Patients

Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial

Lupus Vulgaris Occurring in a Locus Minoris Resistentiae

Successful hair transplant of eyebrow alopecia areata

Successful Hair Transplant of Eyebrow Alopecia Areata

Melanoma cell death induced by sphingosine and betulinic acid [Abstract]

Suchergebnisse filtern